CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of GBP 57.18 billion. The enterprise value is 116.06 billion.

Market Cap	57.18B
Enterprise Value	116.06B

Important Dates

The next estimated earnings date is Wednesday, February 12, 2025.

Earnings Date	Feb 12, 2025
Ex-Dividend Date	Jan 23, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.26B

Valuation Ratios

The trailing PE ratio is 15.28.

PE Ratio	15.28
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.38, with an EV/FCF ratio of 92.21.

EV / Earnings	31.01
EV / Sales	0.39
EV / EBITDA	8.38
EV / EBIT	15.14
EV / FCF	92.21

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.10.

Current Ratio	0.80
Quick Ratio	0.54
Debt / Equity	1.10
Debt / EBITDA	4.80
Debt / FCF	49.02
Interest Coverage	3.30

Financial Efficiency

Return on equity (ROE) is 6.70% and return on invested capital (ROIC) is 3.81%.

Return on Equity (ROE)	6.70%
Return on Assets (ROA)	2.37%
Return on Invested Capital (ROIC)	3.81%
Return on Capital Employed (ROCE)	5.68%
Revenue Per Employee	1.06M
Profits Per Employee	14,422
Employee Count	300,000
Asset Turnover	1.46
Inventory Turnover	17.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.23% in the last 52 weeks. The beta is 0.54, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-23.23%
50-Day Moving Average	51.98
200-Day Moving Average	57.49
Relative Strength Index (RSI)	71.07
Average Volume (20 Days)	16,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.22

Income Statement

In the last 12 months, CVS Health had revenue of GBP 274.00 billion and earned 3.74 billion in profits. Earnings per share was 2.95.

Revenue	274.00B
Gross Profit	37.84B
Operating Income	7.11B
Pretax Income	5.02B
Net Income	3.74B
EBITDA	10.53B
EBIT	7.11B
Earnings Per Share (EPS)	2.95

Full Income Statement

Balance Sheet

The company has 7.22 billion in cash and 61.71 billion in debt, giving a net cash position of -54.48 billion.

Cash & Cash Equivalents	7.22B
Total Debt	61.71B
Net Cash	-54.48B
Net Cash Per Share	n/a
Equity (Book Value)	56.04B
Book Value Per Share	44.45
Working Capital	-12.90B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.44 billion and capital expenditures -2.18 billion, giving a free cash flow of 1.26 billion.

Operating Cash Flow	3.44B
Capital Expenditures	-2.18B
Free Cash Flow	1.26B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.81%, with operating and profit margins of 2.60% and 1.37%.

Gross Margin	13.81%
Operating Margin	2.60%
Pretax Margin	1.83%
Profit Margin	1.37%
EBITDA Margin	3.84%
EBIT Margin	2.60%
FCF Margin	0.46%

Dividends & Yields

This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 3.70%.

Dividend Per Share	2.10
Dividend Yield	3.70%
Dividend Growth (YoY)	6.15%
Years of Dividend Growth	3
Payout Ratio	66.07%
Buyback Yield	2.08%
Shareholder Yield	5.78%
Earnings Yield	6.54%
FCF Yield	2.20%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.13. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.13
Piotroski F-Score	n/a